A new tyrosine kinase inhibitor K905-0266 inhibits proliferation and sphere formation of glioblastoma cancer cells

References

• Society AC. Cancer facts & figures for Hispanics. Atlanta, GA: American Cancer Society; 2009.
   Google Scholar
• Stupp R, Mason WP, Van Den Bent MJ, National Cancer Institute of Canada Clinical Trials Group, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352(10):987–996.
   PubMed Web of Science ®Google Scholar
• Dai C, Holland EC. Astrocyte differentiation states and glioma formation. Cancer J. 2003;9(2):72–81.
   PubMed Web of Science ®Google Scholar
• Shibata M, Shen MM. The roots of cancer: stem cells and the basis for tumor heterogeneity. Bioessays. 2013;35(3):253–260.
   PubMed Web of Science ®Google Scholar
• Chow E-H. Implication of cancer stem cells in cancer drug development and drug delivery. J Lab Autom. 2013;18(1):6–11.
   PubMedGoogle Scholar
• Pointer KB, Clark PA, Zorniak M, et al. Glioblastoma cancer stem cells: biomarker and therapeutic advances. Neurochem Int. 2014;71:1–7.
   PubMed Web of Science ®Google Scholar
• Romaguera-Ros M, Peris-Celda M, Oliver-De La Cruz J, et al. Cancer-initiating enriched cell lines from human glioblastoma: preparing for drug discovery assays. Stem Cell Rev Rep. 2012;8(1):288–298.
   PubMed Web of Science ®Google Scholar
• Chen J, Li Y, Yu T-S, et al. A restricted cell population propagates glioblastoma growth after chemotherapy. Nature. 2012;488(7412):522–526.
   PubMed Web of Science ®Google Scholar
• Singh SK, Hawkins C, Clarke ID, et al. Identification of human brain tumour initiating cells. Nature. 2004;432(7015):396–401.
   PubMed Web of Science ®Google Scholar
• Lathia JD, Mack SC, Mulkearns-Hubert EE, et al. Cancer stem cells in glioblastoma. Genes Dev. 2015;29(12):1203–1217.
   PubMed Web of Science ®Google Scholar
• Cheng L, Huang Z, Zhou W, et al. Glioblastoma stem cells generate vascular pericytes to support vessel function and tumor growth. Cell. 2013;153(1):139–152.
   PubMed Web of Science ®Google Scholar
• Zhou W, Ke SQ, Huang Z, et al. Periostin secreted by glioblastoma stem cells recruits M2 tumour-associated macrophages and promotes malignant growth. Nat Cell Biol. 2015;17(2):170–182.
   PubMed Web of Science ®Google Scholar
• Van Staveren W, Solís DW, Hebrant A, et al. Human cancer cell lines: experimental models for cancer cells in situ? For cancer stem cells? Biochim Biophys Acta (BBA)-Rev Cancer. 2009;1795(2):92–103.
   PubMed Web of Science ®Google Scholar
• Thanasupawat T, Natarajan S, Rommel A, et al. Dovitinib enhances temozolomide efficacy in glioblastoma cells. Mol Oncol. 2017;11(8):1078–1098.
   PubMed Web of Science ®Google Scholar
• Shi Y, Guryanova OA, Zhou W, et al. Ibrutinib inactivates BMX-STAT3 in glioma stem cells to impair malignant growth and radioresistance. Sci Transl Med. 2018;10(443):eaah6816.
   PubMed Web of Science ®Google Scholar
• de Boüard S, Herlin P, Christensen JG, et al. Antiangiogenic and anti-invasive effects of sunitinib on experimental human glioblastoma. Neuro-oncol. 2007;9(4):412–423.
   PubMed Web of Science ®Google Scholar
• Network C. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008; 455:1061.
   PubMed Web of Science ®Google Scholar
• Fan Q-W, Weiss WA. Targeting the RTK-PI3K-mTOR axis in malignant glioma: overcoming resistance. In Phosphoinositide 3-kinase in health and disease. New York: Springer; 2010. p. 279–296.
   Google Scholar
• Thorpe LM, Yuzugullu H, Zhao JJ. PI3K in cancer: divergent roles of isoforms, modes of activation and therapeutic targeting. Nat Rev Cancer. 2015;15(1):7–24.
   PubMed Web of Science ®Google Scholar
• Yoon S, Seger R. The extracellular signal-regulated kinase: multiple substrates regulate diverse cellular functions. Growth Factors. 2006;24(1):21–44.
   PubMed Web of Science ®Google Scholar
• Oh JM, Kalimuthu S, Gangadaran P, et al. Reverting iodine avidity of radioactive-iodine refractory thyroid cancer with a new tyrosine kinase inhibitor (K905-0266) excavated by high-throughput NIS (sodium iodide symporter) enhancer screening platform using dual reporter gene system. Oncotarget. 2018;9(6):7075–7087.
   PubMedGoogle Scholar
• Moodie SA, Willumsen BM, Weber MJ, et al. Complexes of Ras. GTP with Raf-1 and mitogen-activated protein kinase kinase. Science. 1993;260(5114):1658–1661.
   PubMed Web of Science ®Google Scholar
• Thomas SM, DeMarco M, D'Arcangelo G, et al. Ras is essential for nerve growth factor-and phorbol ester-induced tyrosine phosphorylation of MAP kinases. Cell. 1992;68(6):1031–1040.
   PubMed Web of Science ®Google Scholar
• Riddick G, Kotliarova S, Rodriguez V, et al. A core regulatory circuit in glioblastoma stem cells links MAPK activation to a transcriptional program of neural stem cell identity. Sci Rep. 2017;7:43605.
   PubMed Web of Science ®Google Scholar
• Jiang Y, Uhrbom L. On the origin of glioma. Ups J Med Sci. 2012;117(2):113–121.
   PubMed Web of Science ®Google Scholar
• Liu C, Tu Y, Sun X, et al. Wnt/beta-Catenin pathway in human glioma: expression pattern and clinical/prognostic correlations. Clin Exp Med. 2011;11(2):105–112.
   PubMed Web of Science ®Google Scholar
• Zhang X, Chen T, Zhang J, et al. Notch1 promotes glioma cell migration and invasion by stimulating β‐catenin and NF‐κB signaling via AKT activation. Cancer Sci. 2012;103(2):181–190.
   PubMed Web of Science ®Google Scholar
• Lee J, Kotliarova S, Kotliarov Y, et al. Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell. 2006;9(5):391–403.
   PubMed Web of Science ®Google Scholar
• Zhu Z, Khan MA, Weiler M, et al. Targeting self-renewal in high-grade brain tumors leads to loss of brain tumor stem cells and prolonged survival. Cell Stem Cell. 2014;15(2):185–198.
   PubMed Web of Science ®Google Scholar
• Taylor TE, Furnari FB, Cavenee WK. Targeting EGFR for treatment of glioblastoma: molecular basis to overcome resistance. Curr Cancer Drug Targets. 2012;12(3):197–209.
   PubMed Web of Science ®Google Scholar
• Karpel-Massler G, Schmidt U, Unterberg A, et al. Therapeutic inhibition of the epidermal growth factor receptor in high-grade gliomas: where do we stand? Mol Cancer Res. 2009;7(7):1000–1012.
   PubMed Web of Science ®Google Scholar
• Guha A, Feldkamp MM, Lau N, et al. Proliferation of human malignant astrocytomas is dependent on Ras activation. Oncogene. 1997;15(23):2755–2765.
   PubMed Web of Science ®Google Scholar
• Dienstmann R, Rodon J, Serra V, et al. Picking the point of inhibition: a comparative review of PI3K/AKT/mTOR pathway inhibitors. Mol Cancer Ther. 2014;13(5):1021–1031.
   PubMed Web of Science ®Google Scholar
• Roberts PJ, Der CJ. Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene. 2007;26(22):3291–3310.
   PubMed Web of Science ®Google Scholar
• Erhardt P, Schremser EJ, Cooper GM. B-Raf inhibits programmed cell death downstream of cytochrome c release from mitochondria by activating the MEK/Erk pathway. Mol Cell Biol. 1999;19(8):5308–5315.
   PubMed Web of Science ®Google Scholar
• von Gise A, Lorenz P, Wellbrock C, et al. Apoptosis suppression by Raf-1 and MEK1 requires MEK-and phosphatidylinositol 3-kinase-dependent signals. Mol Cell Biol. 2001;21(7):2324–2336.
   PubMed Web of Science ®Google Scholar
• Datta SR, Brunet A, Greenberg ME. Cellular survival: a play in three Akts. Genes Dev. 1999;13(22):2905–2927.
   PubMed Web of Science ®Google Scholar
• Reed JC. Dysregulation of apoptosis in cancer. J Clin Oncol. 1999;17(9):2941–2953.
   PubMed Web of Science ®Google Scholar
• Wang J, Liu X, Hong Y, et al. Ibrutinib, a Bruton’s tyrosine kinase inhibitor, exhibits antitumoral activity and induces autophagy in glioblastoma. J Exp Clin Cancer Res. 2017;36(1):96.
   PubMed Web of Science ®Google Scholar
• Weissman IL, Anderson DJ, Gage F. Stem and progenitor cells: origins, phenotypes, lineage commitments, and transdifferentiations. Annu Rev Cell Dev Biol. 2001;17:387–403.
   PubMed Web of Science ®Google Scholar
• Hong X, Chedid K, Kalkanis SN. Glioblastoma cell line-derived spheres in serum‑containing medium versus serum-free medium: a comparison of cancer stem cell properties. Int J Oncol. 2012;41(5):1693–1700.
   PubMed Web of Science ®Google Scholar